Shifting Paradigms of Surgical Management in Advanced Ovarian Cancer

SSuMOC Trial: shifting paradigms of surgical management in advanced ovarian cancer - SSuMOC Trial: shifting paradigms of surgical management in advanced ovarian cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049535

Enrollment

550

Registered

2022-11-16

Start date

2018-07-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

FIGO sage III/IV Epithelial Ovarian Cancer

Interventions

None listed

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Patients with an advanced stage of epithelial ovarian cancer who are eligible for surgical cytoreductive treatment

Exclusion criteria

Exclusion criteria: Patients with recurrent ovarian cancer Patients with a synchronous primary tumour Patients with non-epithelial ovarian cancer Patient with comorbidities that makes them ineligible for cytoreductive surgery

Design outcomes

Primary

Measure	Time frame
Complete surgical cytoreduction rates	—

Secondary

Measure	Time frame
Morbidity	—

Countries

Europe

Contacts

Public ContactAlexandros Laios

St. James's University Hospital LTHT Department of Gynaecological Oncology

a.laios@nhs.net+44(0)1132068251

Outcome results